Login/Sign Up
Bufatas 60 mg Injection 10 ml belongs to a group of medicines called cytotoxics (also called chemotherapy). Busulfan is used for certain blood problems and cancers of the blood such as Chronic myeloid leukaemia, Polycythaemia vera, Thrombocythemia, and Myelofibrosis. On the other side, it can be used in bone marrow or stem cell transplant therapy. Blood cancers are cancers that develop in the blood. This can affect the production of blood cells and also how they work.
Bufatas 60 mg Injection 10 ml contains Busulfan, which works by interfering with the production of blood cell DNA. Thus, it prevents the cells from growing and maturing, which ultimately leads to the death of these cells.
Bufatas 60 mg Injection 10 ml should be administered to patients only in a hospital setting under the supervision of a physician qualified by training and experience to administer cancer chemotherapeutic agents. The most common adverse reactions that occur while on therapy are feeling or being sick, anaemia, bruising, bleeding gums or nosebleeds, headaches, tummy pain, constipation, diarrhoea, loss of appetite, liver changes, and increased risk of getting an infection, Symptoms include a change in temperature, aching muscles, headaches, feeling cold and shivery and generally unwell. Most of these side effects of Bufatas 60 mg Injection 10 ml do not require medical attention and gradually resolve over time. However, if the side effects persist, contact your doctor.
To treat your condition effectually, continue taking Bufatas 60 mg Injection 10 ml for as long as your doctor has prescribed. It is expected to cause fetal harm when administered to a pregnant woman, so it should not be used in pregnant women. Both women and men using this Bufatas 60 mg Injection 10 ml should use birth control to avoid pregnancy. Discontinue nursing while on therapy, considering the importance of the drug to the mother. Caution should be exercised while using Bufatas 60 mg Injection 10 ml in patients with infections, hepatic, renal, heart dysfunction and or Lower-than-normal levels of blood count, so inform your doctor about all your medical conditions and medications you are currently taking.
Bufatas 60 mg Injection 10 ml contains Busulfan, which belongs to a group of medicines called cytotoxics (also called chemotherapy). It works by interfering with the production of blood cell DNA. Thus, it prevents the cells from growing and maturing, which ultimately leads to the death of these cells. Thereby, it treats certain blood problems and cancers of the blood, such as Chronic myeloid leukaemia, Polycythaemia vera, Thrombocythemia, and Myelofibrosis.
Before taking the Bufatas 60 mg Injection 10 ml, let your doctor know about all your allergic or hypersensitivity reactions to medicines or food. Before taking Bufatas 60 mg Injection 10 ml, inform your doctor about your medical history and other medications you are currently taking in order to rule out any potential negative effects. Bufatas 60 mg Injection 10 ml may cause fertility problems in women if they take it. Please discuss this with their doctor before starting treatment. Women of childbearing age should use effective contraception during and up to 3 months after treatment with Bufatas 60 mg Injection 10 ml. Avoid the consumption of alcoholic beverages. Busulfan may raise your chances of developing other types of cancer. Discuss the risks of receiving busulfan with your doctor. It is recommended not to take you. You have taken Busulfan before, and it did not work.
Drug-Drug Interactions: Bufatas 60 mg Injection 10 ml interacts with immunomodulatory medication (e..g adalimumab, ozanimod), vaccinations (e.g. BCG Vaccine, dengue vaccine, influenza virus vaccine, live), antipsychotic medications (e.g. Clozapine), medication used for the treatment of moderate-to-severe plaque psoriasis (e.g. deucravacitinib) and antirheumatic drug (e.g. leflunomide).
Drug-Food Interactions: Do not drink grapefruit juice or alcoholic beverages while you are being treated with Bufatas 60 mg Injection 10 ml. It can affect the way the medicine works.
Drug-Disease Interactions: Bufatas 60 mg Injection 10 ml may potentially interact with various disease conditions, including infections (bacterial/fungal/protozoal/viral), myelosuppression (Bone Marrow Depression/Low Blood Counts, Fever, Bleeding), severe hepatic and renal impairment.
Cancer: Cancer is a condition where cells in a specific body part grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs. Cancer sometimes begins in one body part before spreading to other areas.
Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It is a type of cancer that begins in the bone marrow's blood-forming cells.
Polycythemia vera is a form of blood cancer (pol-e-sy-THEE-me-uh VEER-uh). It causes your bone marrow to produce an abnormally large number of red blood cells. These extra cells thicken your blood, delaying its flow and even causing major complications like blood clots.
Essential thrombocythemia (ET) is a rare blood condition that causes an abnormally large amount of platelets to develop in the blood. These are blood cells that help with coagulation. Clotting is referred to as thrombosis, and blood cells are referred to as cythaemia.
Myelofibrosis (MF) is a rare type of blood cancer characterized by the formation of scar tissue, known as 'fibrosis,' in the bone marrow. As scar tissue grows, the bone marrow is unable to produce enough healthy blood cells.
About Bufatas 60 mg Injection 10 ml
Bufatas 60 mg Injection 10 ml belongs to a group of medicines called cytotoxics (also called chemotherapy). Busulfan is used for certain blood problems and cancers of the blood such as Chronic myeloid leukaemia, Polycythaemia vera, Thrombocythemia, and Myelofibrosis. On the other side, it can be used in bone marrow or stem cell transplant therapy. Blood cancers are cancers that develop in the blood. This can affect the production of blood cells and also how they work.
Bufatas 60 mg Injection 10 ml contains Busulfan, which works by interfering with the production of blood cell DNA. Thus, it prevents the cells from growing and maturing, which ultimately leads to the death of these cells.
Bufatas 60 mg Injection 10 ml should be administered to patients only in a hospital setting under the supervision of a physician qualified by training and experience to administer cancer chemotherapeutic agents. The most common adverse reactions that occur while on therapy are feeling or being sick, anaemia, bruising, bleeding gums or nosebleeds, headaches, tummy pain, constipation, diarrhoea, loss of appetite, liver changes, and increased risk of getting an infection, Symptoms include a change in temperature, aching muscles, headaches, feeling cold and shivery and generally unwell. Most of these side effects of Bufatas 60 mg Injection 10 ml do not require medical attention and gradually resolve over time. However, if the side effects persist, contact your doctor.
To treat your condition effectually, continue taking Bufatas 60 mg Injection 10 ml for as long as your doctor has prescribed. It is expected to cause fetal harm when administered to a pregnant woman, so it should not be used in pregnant women. Both women and men using this Bufatas 60 mg Injection 10 ml should use birth control to avoid pregnancy. Discontinue nursing while on therapy, considering the importance of the drug to the mother. Caution should be exercised while using Bufatas 60 mg Injection 10 ml in patients with infections, hepatic, renal, heart dysfunction and or Lower-than-normal levels of blood count, so inform your doctor about all your medical conditions and medications you are currently taking.
₹9538.7*
MRP ₹11632.5
18% off
₹9887.62*
MRP ₹11632.5
15% CB
₹1744.88 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Online payment accepted
Uses of Bufatas 60 mg Injection 10 ml
Medicinal Benefits
Bufatas 60 mg Injection 10 ml contains Busulfan, which belongs to a group of medicines called cytotoxics (also called chemotherapy). It works by interfering with the production of blood cell DNA. Thus, it prevents the cells from growing and maturing, which ultimately leads to the death of these cells. Thereby, it treats certain blood problems and cancers of the blood, such as Chronic myeloid leukaemia, Polycythaemia vera, Thrombocythemia, and Myelofibrosis.
Side Effects of Bufatas 60 mg Injection 10 ml
Directions for Use
Storage
Drug Warnings
Before taking the Bufatas 60 mg Injection 10 ml, let your doctor know about all your allergic or hypersensitivity reactions to medicines or food. Before taking Bufatas 60 mg Injection 10 ml, inform your doctor about your medical history and other medications you are currently taking in order to rule out any potential negative effects. Bufatas 60 mg Injection 10 ml may cause fertility problems in women if they take it. Please discuss this with their doctor before starting treatment. Women of childbearing age should use effective contraception during and up to 3 months after treatment with Bufatas 60 mg Injection 10 ml. Avoid the consumption of alcoholic beverages. Busulfan may raise your chances of developing other types of cancer. Discuss the risks of receiving busulfan with your doctor. It is recommended not to take you. You have taken Busulfan before, and it did not work.
Therapeutic Class
Drug-Drug Interactions Checker List
Diet & Lifestyle Advise
Habit Forming
Special Advise
Disease/Condition Glossary
Cancer: Cancer is a condition where cells in a specific body part grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs. Cancer sometimes begins in one body part before spreading to other areas.
Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It is a type of cancer that begins in the bone marrow's blood-forming cells.
Polycythemia vera is a form of blood cancer (pol-e-sy-THEE-me-uh VEER-uh). It causes your bone marrow to produce an abnormally large number of red blood cells. These extra cells thicken your blood, delaying its flow and even causing major complications like blood clots.
Essential thrombocythemia (ET) is a rare blood condition that causes an abnormally large amount of platelets to develop in the blood. These are blood cells that help with coagulation. Clotting is referred to as thrombosis, and blood cells are referred to as cythaemia.
Myelofibrosis (MF) is a rare type of blood cancer characterized by the formation of scar tissue, known as 'fibrosis,' in the bone marrow. As scar tissue grows, the bone marrow is unable to produce enough healthy blood cells.